Published: Guidance, quality standards and advice

Skip to filters Skip to results

Showing 776 to 800 of 911

Sort by

Type: GuidanceRemove Type: Guidance filter
Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter
Guidance programme: Highly specialised technologies guidanceRemove Guidance programme: Highly specialised technologies guidance filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome	HST31	22 May 2024	22 May 2024
Setmelanotide for treating obesity caused by LEPR or POMC deficiency	HST21	6 July 2022	6 July 2022
Siponimod for treating secondary progressive multiple sclerosis	TA656	18 November 2020	18 November 2020
Sirolimus for treating facial angiofibroma caused by tuberous sclerosis complex in people 6 years and over (terminated appraisal)	TA972	22 May 2024	27 January 2026
Slow-release potassium bicarbonate–potassium citrate for treating distal renal tubular acidosis (terminated appraisal)	TA838	2 November 2022	2 November 2022
Sodium zirconium cyclosilicate for treating hyperkalaemia	TA599	4 September 2019	24 January 2022
Sofosbuvir for treating chronic hepatitis C	TA330	25 February 2015	25 February 2015
Sofosbuvir–velpatasvir for treating chronic hepatitis C	TA430	25 January 2017	25 January 2017
Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C	TA507	21 February 2018	21 February 2018
Solriamfetol for treating excessive daytime sleepiness caused by narcolepsy	TA758	5 January 2022	5 January 2022
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea	TA777	9 March 2022	9 March 2022
Somapacitan for treating growth hormone deficiency in people 3 to 17 years	TA1066	3 June 2025	3 June 2025
Somatrogon for treating growth disturbance in children and young people aged 3 years and over	TA863	1 February 2023	1 February 2023
Sorafenib for treating advanced hepatocellular carcinoma	TA474	6 September 2017	6 September 2017
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer	TA781	30 March 2022	30 March 2022
Sparsentan for treating primary IgA nephropathy	TA1074	25 June 2025	9 October 2025
Spesolimab for treating generalised pustular psoriasis flares	TA1070	18 June 2025	18 June 2025
Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin	TA159	22 October 2008	22 October 2008
Stapled haemorrhoidopexy for the treatment of haemorrhoids	TA128	26 September 2007	26 September 2007
Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency	HST7	7 February 2018	7 February 2018
Structural neuroimaging in first-episode psychosis	TA136	27 February 2008	27 February 2008
Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma	TA169	25 March 2009	25 March 2009
Sunitinib for the treatment of gastrointestinal stromal tumours	TA179	23 September 2009	23 September 2009
Tabelecleucel for treating post-transplant lymphoproliferative disorder caused by the Epstein-Barr virus (terminated appraisal)	TA923	19 October 2023	19 October 2023
Tacrolimus and pimecrolimus for atopic eczema	TA82	25 August 2004	25 August 2004

Results per page

10
25
50
All